Annual Meeting

[breadcrumb_simple]

Pancreas Club 2020 Virtual Meeting | Scientific Schedule

Thursday, October 22, 2020

9:45am – 10:00am EDT

Opening Comments


10:00am – 1:00pm EDT

Scientific Session 1 | Moderator: William H. Nealon MD; Northwell Health

10:00am EDT – 10:15am EDT
1. SMAD4 LOSS IS ASSOCIATED WITH RESPONSE TO NEOADJUVANT CHEMOTHERAPY WITH THE AUTOPHAGY INHIBITOR HYDROXYCHLOROQUINE IN PATIENTS WITH PANCREATIC ADENOCARCINOMA
P Rao, S Wen, N Fei , R Ramanathan, ME Hogg, A Zureikat, MT Lotze, N Bahary, AD Singhi, HJ Zeh, BA Boone
Presenter: Pavan Rao MD | West Virginia University School of Medicine

10:15am EDT – 10:30am EDT
2. ENHANCEMENT OF THE TUMOR MICROENVIRONMENT IMMUNE RESPONSE IN PANCREATIC DUCTAL ADENOCARCINOMA PATIENTS AFTER NEOADJUVANT THERAPY
T Michelakos, F Kontos, Y Sekigam EDTi, L Cai, V Villani, F Sabbatino, A Neyaz, C Fernández-del Castillo, MS Taylor, V Deshpande, DT Ting, M Qadan, JN Allen, JW Clark, TS Hong, DP Ryan, JY Wo, AL Warshaw, KD Lillemoe, S Ferrone, CR Ferrone
Presenter: Theodoros Michelakos MD | Massachusetts General Hospital

10:30am EDT – 10:45am EDT
3. TARGETING GUT MICROBIAL DYSBIOSIS TO COUNTERACT TUMOR PERMISSIVE EFFECTS OF SMOKING ON PANCREATIC CANCER
P Sharma, T Jain, V Sethi, S Kurtom, P Roy, J Tao, H Jacob, A Ferrantella, B Giri, M Tarique, S Iyer, D Edwards, B Gomez, S Lavania, S Ramakrishnan, R Dawra, A Saluja, V Dudeja
Presenter: Prateek Sharma MBBS | University of Miami

10:45am EDT – 11:00am EDT
4. EVALUATING THE IMMUNE MODULATORY EFFECTS OF A TARGETED ANICANCER THERAPY, ACXT-3102, IN MURINE MODEL OF PANCREATIC CANCER
UY Panni, J Herndon, D Spitzer, D DeNardo, WG Hawkins
Presenter: Usman Y Panni MD | Washington University in St. Louis

11:00am EDT – 11:15am EDT
5. HIGH-FAT, HIGH-CALORIE DIET PROMOTES PANCREATIC NEOPLASIA IN KRASG12D +/- MOUSE MODEL
Z Lu, G Wang, H Gao, L Yin, Y Gao, J Zhang, K Zhang, K Jiang, Y Miao
Presenter: Zipeng Lu MD, PhD | The First Affilliated Hospial with Nanjing Medical University

11:30am EDT – 11:35am EDT
7. ALIGNMENT OF STROMA FIBERS AND MICROVESSEL DENSITY DETERMINE OVERALL SURVIVAL IN PANCREATIC CANCER – AN ANALYSIS OF STROMA MORPHOLOGY
L Bolm, P Zgurskiy, H Lapshyn, E Petrova, YK Vashist, S Deichmann, KC Honselmann, P Bronsert,  T Keck, UF Wellner
Presenter: Louisa R Bolm MD | University Medical Center Schleswig-Holstein, Campus Luebeck

11:35am EDT – 11:40am EDT
8. UTILIZING OXALIPLATIN AND OLAPARIB TO DEVELOP AN IMMUNOGENIC MURINE PANCREATIC CANCER MODEL
UY Panni, DR Cullinan, P Goedegebuure, KH Lim, DG DeNardo, WE Gillanders, WG Hawkins
Presenter: Usman Y Panni MD | Washington University in St. Louis

11:40am EDT – 11:45am EDT
9. CHARACTERIZATION OF MACROPHAGE ISOCITRATE DEHYDROGENASE 1
J Hue, A Vaziri-Gohar, S Chelstowska, H Graor, S Huang, J Winter
Presenter: Jonathan J Hue MD | Case Western Reserve University School of Medicine

11:45am EDT – 12:00pm EDT
10. GEOGRAPHIC VARIATION IN ATTITUDES REGARDING LOCALLY ADVANCED PANCREATIC CANCER MANAGEMENT
BN Ream EDTes, AB Blair, RW Krell, A Ejaz, VP Groot, G Gemenetzis, JC Padussis, SP Thayer, M Falconi, CL Wolfgang, MJ Weiss, C Are, J He
Presenter: Bradley N Ream EDTes MD, MS | University of Nebraska Medical Center

12:00pm EDT – 12:05pm EDT
11. THE ROLE OF POSITRON EMISSION TOMOGRAPHY SCAN DERIVED PARAM EDTETERS IN PREDICTION OF RESPONSE AFTER NEOADJUVANT CHEMOTHERAPY FOR BORDERLINE RESECTABLE AND LOCALLY ADVANCED PANCREATIC CANCER
SC Kim, W Lee
Presenter: Woohyung Lee | Asan Medical Center

12:05pm EDT – 12:20pm EDT
12. POSTOPERATIVE CHEMOTHERAPY BENEFITS PATIENTS WHO RECEIVED PREOPERATIVE THERAPY AND PANCREATECTOMY FOR PANCREATIC ADENOCARCINOMA
G Perri, L Prakash, W Qiao, GR Varadhachary, R Wolff, D Fogelman, M Overman, S Pant, M Javle, EJ Koay, J Herman, M Kim, N Ikoma, C Tzeng, JE Lee, MHG Katz
Presenter: Giampaolo Perri MD | University of Texas MD Anderson Cancer Center

12:20pm EDT – 12:35pm EDT
13. AGGRESSIVE SURGERY FOR SELECTED PATIENTS WITH PANCREATIC CANCER AND ISOLATED LIVER METASTASIS
WR Burns, M Nagai, D Ding, MJ Wright, ED Thompson, AA Javed, MJ Weiss, RH Hruban, J Yu, RA Burkhart, J He, JL Cam EDTeron, CL Wolfgang
Presenter: Minako Nagai | Johns Hopkins University School of Medicine

12:35pm EDT – 12:40pm EDT
14. PANCREATIC CANCER RISK DETERMINATION IN PATIENTS WITH NEW-ONSET TYPE 2 DIABETES MELLITUS
KJ Lee, LL Price, L Scheuer, S Curry, M Hodge, T Schnelldorfer
Presenter: Ki J Lee | Lahey Hospital and Medical Center

12:40pm EDT – 12:45pm EDT
15. THE INFLUENCE OF EDUCATION AND SUPPORT CLASS ROOM FOR PANCREATIC CANCER PATIENTS AND FAM EDTILY BY THE MEDICAL TEAM EDT “SUIGAN-KYOUSHITSU“: A QUESTIONNAIRE SURVEY
M Kishiwada, AHayasaki, K Gyoten, T Fujii, Y Iizawa,  A Tanemura, Y Murata, N Kuriyam EDTa, H Sakurai, S Mizuno
Presenter: Masashi Kishiwada MD, PhD | Mie University School of Medicine

12:45pm EDT – 1:00pm EDT
16. IMPROVED OUTPATIENT COMMUNICATION DRAM EDTATICALLY DECREASES UNPLANNED READMISSION IN NECROTIZING PANCREATITIS
TK Maatman, KA McGreevy, AJ Sood, EP Ceppa, MG House, A Nakeeb, CM Schmidt, NJ Zyromski
Presenter: Thomas K Maatman MD | Indiana University School of Medicine


1:00pm – 3:00pm EDT

Afternoon Break


3:00pm – 6:00pm EDT

Scientific Session 2 | Moderator: Christopher Wolfgang MD, PhD; Johns Hopkins Medicine

3:00pm EDT – 3:15pm EDT
17. TRANSGASTRIC DEBRIDEMENT IN NECROTIZING PANCREATITIS: ENDOSCOPIC OR OPERATIVE?
TK Maatman, BL Bick, EP Ceppa, JM DeWitt, JJ Easler, KF Flick, EL Fogel, MA Gromski, MG House, A Nakeeb, MA Al-Haddad, S Sherman, NJ Zyromski
Presenter: Thomas K Maatman MD | Indiana University School of Medicine

3:15pm EDT – 3:30pm EDT
18. INCIDENCE AND MANAGEMENT OF VASCULAR COMPLICATIONS IN PATIENTS TREATED WITH A MINIMALLY INVASIVE STEP UP APPROACH TO NECROTIZING PANCREATITIS: AN OBSERVATIONAL COHORT STUDY
CM Luckhurst , M El Hechi, LR Maurer, K Yamada, K Krishnan, C Fernandez-Del Castillo, KD Lillemoe, PJ Fagenholz
Presenter: Casey Luckhurst MD | Massachusetts General Hospital

3:30pm EDT – 3:45pm EDT
19. ASSESING THE ROLE OF IRRIGATION OF THE CAVITY WITH STREPTOKINASE VS HYDROGEN PEROXIDE IN IMPROVING THE EFFICACY OF PERCUTANEOUS CATHETER DRAINAGE IN SEVERE ACUTE NECROTIZING PANCREATITIS
VB Mulpuri, SS Rana, U Gorsi, M Kang, H Singh, R Gupta
Presenter: Venu Bhargava Mulpuri MBBS, MS, Mch | Postgraduate Institute of Medical Education And Research

3:45pm EDT – 3:50pm EDT
20. IMPACT OF LUMEN-APPOSING METAL STENTS ON THE LONG-TERM MANAGEMENT OF DISCONNECTED PANCREATIC DUCT SYNDROME
JY Bang, R Hawes, S Varadarajulu
Presenter: Ji Young Bang MD, MPH | AdventHealth Orlando

3:55pm EDT – 4:00pm EDT
22. ASSOCIATION BETWEEN CHRONIC PANCREATITIS AND PANCREATIC CANCER: A TEN-YEAR RETROSPECTIVE STUDY OF ENDOSCOPICALLY TREATED AND SURGICAL PATIENTS
T Korpela, M Udd, H Mustonen, A Ristimäki, C Haglund, H Seppänen, L Kylänpää
Presenter: Taija Korpela | Helsinki University Hospital

4:00pm EDT – 4:05pm EDT
23. VASOSTATIN-1 AS PANCREATIC NEUROENDOCRINE TUMOR BIOMARKER: A COMPARISON BETWEEN PREOPERATIVE AND POSTOPERATIVE MEASUREMENTS
V Andreasi, S Partelli, M Manzoni, F Muffatti, B Colombo, RM Montorsi, A Corti, M Falconi
Presenter: Valentina Andreasi | San Raffaele Scientific Institute

4:05pm EDT – 4:20pm EDT
24. PREDICTORS AND PATTERNS OF RECURRENCE AFTER SURGERY FOR NONFUNCTIONING PANCREATIC NEUROENDOCRINE NEOPLASMS: IMPLICATIONS FOR FOLLOW-UP STRATEGY
S Partelli, G Guarneri, L De Mestier, S Gaujoux, V Andreasi, P Rancoita, S Dokmak, P Ruszniewski, A Sauvanet, M Falconi
Presenter: Valentina Andreasi | San Raffaele Scientific Institute

4:20pm EDT – 4:35pm EDT
25. INTERIM ANALYSIS OF PROSPECTIVE EVALUATION OF THE MANAGEMENT OF SPORADIC NONFUNCTIONING ASYMPTOMATIC PANCREATIC NEUROENDOCRINE NEOPLASMS ≤ 2 CM (ASPEN STUDY)
S Partelli, A Zerbi, S Massironi, J Jin-Young, L Landoni, EN Van Dijkum, J Ram EDTage, V Andreasi, E Segelov, T Armstrong, P Niccoli, A Sauvanet, M Falconi
Presenter: Stefano Partelli | San Raffaele Scientific Institute

4:35pm EDT – 4:50pm EDT
26. DETECTION STUDY: DIAGNOSTIC ACCURACY OF 68GA-PET, ENDOSCOPIC ULTRASOUND AND COMPUTED TOMOGRAPHY IN THE ASSESSMENT OF LYMPHNODAL METASTASES BY NONFUNCTIONING PANCREATIC NEUROENDOCRINE NEOPLASMS
F Muffatti, S Partelli, V Andreasi, F Giannone, G Guarneri, C Giorgi, F De Cobelli, P Mapelli, G Rossi, M Picchio, PG Arcidiacono, M Falconi
Presenter: Francesca Muffatti | San Raffaele Scientific Institute

4:50pm EDT – 5:05pm EDT
27. CDK5 DRIVES THE PHOSPHOPROTEOMICS OF PANCREATIC NEUROENDOCRINE TUMORS AND IS A THERAPEUTIC TARGET
AC Carter, JA Bibb, R Telange, W Howse, J Schrader, C Tan, B Robinson, S Reddy
Presenter: Sushanth Reddy MD | University of Alabama at Birmingham

5:05pm EDT – 5:10pm EDT
28. SOMATIC ALTERATIONS IN SPORADIC PANCREATIC NEUROENDOCRINE TUMORS: IS THERE A ROLE FOR TESTING?
CN Clarke, EA Strong, M Gracz, A Livingston, M Aldakkak, K Christians, B George, J Thomas, WA Hall, BA Erickson, DB Evans, S Tsai
Presenter: Erin A Strong MD, MBA, MPH | Medical College of Wisconsin

5:10pm EDT – 5:15pm EDT
29. IS ENUCLEATION SAFE FOR SMALL PANCREATIC NEUROENDOCRINE TUMORS LESS THAN TWO CENTIMETERS IN SIZE?
M Altimari, J Abad, A Chawla
Presenter: Marc Altimari BS | Northwestern Medicine

5:15pm EDT – 5:30pm EDT
30. EXTENDED EXPERIENCE WITH A DYNAM EDTIC, DATA-DRIVEN DRAIN MANAGEMENT PROTOCOL IN PANCREATODUODENECTOMY: PROGRESSIVE RISK STRATIFICATION FOR BETTER PRACTICE
MT Trudeau, L Maggino, B Chen, MT McMillan, MK Lee, R Roses, R DeMatteo, JA Drebin, CM Vollmer
Presenter: Maxwell T Trudeau BS | University of Pennsylvania

5:30pm EDT – 5:45pm EDT
31. CHANGE IN DRAIN AM EDTYLASE IN THE EARLY POSTOPERATIVE PERIOD IS A BETTER PREDICTOR OF CR-POPF THAN USING POD 1 DRAIN AM EDTYLASE ALONE
SB Ahmad, JC Hodges, A Bilderback, A Paniccia, DL Bartlett, AH Zureikat
Presenter: Sarwat Ahmad  | University of Pittsburgh Medical Center

5:45pm EDT – 5:50pm EDT
32. TRANSIENT BILIARY FISTULA AFTER PANCREATODUODENECTOMY INCREASES RISK OF BILIARY ANASTOMOTIC STRICTURE
TK Maatman, AJ Loncharich, KF Flick, RE Simpson, EP Ceppa, A Nakeeb, TK Nguyen, CM Schmidt, NJ Zyromski, MG House
Presenter: Thomas K Maatman MD | Indiana University School of Medicine

5:50pm EDT – 5:55pm EDT
33. PORTAL VEIN THROMBOSIS AFTER VENOUS RECONSTRUCTION DURING PANCREATECTOMY: TIMING AND RISKS
AM Roch, EM Kilbane, TK Nguyen, EP Ceppa, NJ Zyromski, CM Schmidt, A Nakeeb, MG House
Presenter: Alexandra M Roch MD, MS | Indiana University School of Medicine

Friday, October 23, 2020

10:00am – 12:40pm EDT

Scientific Session 3 | Moderator: Marc Besselink MD; Amsterdam UMC

10:00am EDT – 10:15am EDT
34. SHORT-TERM OUTCOMES AFTER TOTAL PANCREATECTOMY: A EUROPEAN PROSPECTIVE MODIFIED-SNAPSHOT STUDY
AEJ Latenstein, L Scholten, M Erkan, J Kleeff, M Lesurtel, B Björnsson, G Capretti, NA Chatzizacharias, I Frigerio, S Gasteiger, A Halimi, KJ Labori, K Mentor, L Muñoz-Bellvis, AN Nikov, I Passas, M de Pastena, M Petric, R Salvia, F Sanchez-Bueno, M Serra
Presenter: Anouk Latenstein  | Academic Medical Center

10:15am EDT – 10:30am EDT
35. DEFINING POSTOPERATIVE WEIGHT CHANGE FOLLOWING PANCREATECTOMY: FACTORS ASSOCIATED WITH DISTINCT AND DYNAM EDTIC WEIGHT TRAJECTORIES
MT Trudeau, L Maggino, BL Ecker, MK Lee, R Roses, R Dematteo, D Fraker, JA Drebin, CM Vollmer
Presenter: Maxwell T Trudeau BS | University of Pennsylvania

10:30am EDT – 10:45am EDT
36. EPIDURAL ANALGESIA IS ASSOCIATED WITH PROLONGED LENGTH OF STAY AFTER OPEN HPB SURGERY IN OVER 27,000 PATIENTS
L Kone, V Maker, M Banulescu, A Maker
Presenter: Lyonell Kone MD, MHS | University of Illinois at Chicago / Metropolitan Group Hospital

11:00am EDT – 11:15am EDT
38. GENE EXPRESSION ANALYSIS OF LASER CAPTURE MICRODISSECTED PDAC TUMORS IDENTIFIES MOLECULAR SUBTYPES OF CANCER AND ADJACENT STROMA
SKS Begg, SKS Begg, DJ Birnbaum, P Finetti, M Mino-Kenudson, KD Lillemoe, AL Warshaw, C Fernández-del Castillo, DT Ting, AS Liss
Presenter: Sebastian Begg BS | Massachusetts General Hospital

11:15am EDT – 11:30am EDT
40. THE IDENTIFICATION OF NON-V600E BRAF MUTATIONS IN GNAS-MUTANT INTRADUCTAL PAPILLARY MUCINOUS NEOPLASMS
A Paniccia, M Nikiforova, K McGrath, R Brand, K Fasanella, R Das, H Singh, A Khalid, J Chennat, S Sarkaria, W Park, A O’Broin-Lennon, J Klapm EDTan, B Centeno, J Nasr, N Kubiliun, A Tavakkoli, H Vanderveldt, J DeWitt, M Wallace, A Slivka, A Wald, K Lee, D Bar
Presenter: Alessandro Paniccia MD | University of Pittsburgh Medical Center

11:30am EDT – 11:45am EDT
42. PRESENCE OF TRANSITIONAL CIRCULATING TUMOR CELLS FOLLOWING RESECTION IS ASSOCIATED WITH WORSE SURVIVAL IN PATIENTS WITH DELAYED INITIATION OF ADJUVANT THERAPY
A Hasanain, AA Javed, AF van Oosten, G Gemenetzis, VP Groot, D Ding, J Teinor, MJ Wright, J Yu, JL Cam EDTeron, MJ Weiss, WR Burns III, RA Burkhart, L Zheng, J He, CL Wolfgang
Presenter: Alina Hasanain MD | Johns Hopkins University School of Medicine

11:45am EDT – 12:00pm EDT
43. A QUANTITATIVE GLOBAL PROTEOMICS APPROACH IDENTIFIES CANDIDATE URINARY BIOMARKERS THAT CORRELATE WITH INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM DYSPLASIA
CM Schmidt, KF Flick, MT Yip-Schneider, CM Sublette, RE Simpson, M Soufi, JM Dewitt, AL Mosley, EP Ceppa, J Zhang
Presenter: Katelyn Flick MD | Indiana University School of Medicine

12:00pm EDT – 12:05pm EDT
44. DELETERIOUS GERMLINE MUTATIONS OF PANCREATIC DISEASES IN CHINESE POPULATION: TARGETED DNA SEQUENCING OF 1,979 CASES
L Yin, J Wei, Z Lu, W Gao, S Huang, H Gao, J Wu, Q Li, K Jiang, C Wolfgang, J Yu, Y Miao
Presenter: Lingdi Yin MD | Pancreas Center, the First Affiliated Hospital of Nanjing Medical University

12:05pm EDT – 12:10pm EDT
45. TRANSCRIPTOMIC VARIATION EXISTS BETWEEN UNTREATED AND FOLFIRINOX-TREATED PANCREATIC DUCTAL ADENOCARCINOMA SPECIMENS AS REVEALED BY SINGLE-CELL RNA SEQUENCING ANALYSIS
JM Harrison, J Chang, M Piquet, S Dimitrieva, H Horn, M Gabriel, T Hank, KD Lillemoe, AL Warshaw, M Mino-Kenudson, C Fernandez-del Castillo, V Cremasco, D Ruddy, AS Liss
Presenter: Jon M Harrison MD | Massachusetts General Hospital

12:10pm EDT – 12:25pm EDT
46. CLINICAL SIGNIFICANCE OF LEUKEMIA INHIBITORY FACTOR (LIF) AND ITS RECEPTORS IN PANCREATIC ADENOCARCINOMA
D Wang, W Guo, ZT Zhang, J Yu
Presenter: Dong Wang MD | Johns Hopkins University School of Medicine

12:25pm EDT – 12:40pm EDT
47. INCIDENTAL DIAGNOSIS OF ASYMPTOMATIC PANCREATIC DUCTAL ADENOCARCINOMA IS ASSOCIATED WITH IMPROVED PATIENT OUTCOMES – CLINICAL APPLICATION OF CANCERSEEK
AA Javed, MJ Wright, D Ding,  KJ LaFaro, J Greer, RA Burkhart, WR Burns, MJ Weiss, JL Cam EDTeron,  J He, CL Wolfgang
Presenter: Ammar A Javed MD | Johns Hopkins University School of Medicine


1:00pm – 3:00pm EDT

Afternoon Break


3:00pm – 5:30pm EDT

Scientific Session 4 | Moderator: Nicholas Zyromski MD; Indiana University

3:00pm EDT – 3:15pm EDT
48. PANCREATIC AND BILIARY CARCINOMA CIRCULATING TUMOR CELLS PROMOTE MYELOID DIFFERENTIATION SIGNALING TO AID IN THEIR SURVIVAL IN THE PORTAL VENOUS CIRCULATION
A Rosales, JP Arnoletti, N Fanaian, SA Litherland
Presenter: Armando Rosales MD | AdventHealth Orlando

3:15pm EDT – 3:30pm EDT
49. IMPLICATIONS OF SMAD4 STATUS IN RECURRENT PANCREATIC DUCTAL ADENOCARCINOMA
S AlMasri, M Zenati, A Singhi, K Lee, N Bahary, D Bartlett, A Zureikat
Presenter: Samer S Al Masri MD | University of Pittsburgh Medical Center

3:30pm EDT – 3:45pm EDT
50. THE METABOLOME ADDS PROGNOSTIC INFORMATION TO COAGULATION ASSESSMENT IN PREDICTING DISEASE FREE SURVIVAL IN PATIENTS UNDERGOING PANCREATIC RESECTION FOR ADENOCARCINOMA
H Moore, A Schulick, A D’Alessandro, K Hansen, T Nydam, E Moore, R Schulick, J Pomposelli, W Messersmith, M Del Chiaro
Presenter: Hunter Moore MD, PhD | University of Colorado

3:45pm EDT – 3:50pm EDT
51. CLINICAL TRIALS IN PANCREATIC CANCER: AN OVERVIEW OF CURRENT PROGRESS
E Katayama, J Hue, J Winter
Presenter: Erryk Katayama | Case Western Reserve University School of Medicine

3:50pm EDT – 3:55pm EDT
52. PANCREATIC CANCER RISK PREDICTION MODEL USING A MULTI-BIOMARKER PANEL
YJ Choi, W Yoon, Y Byun, JS Kang, HS Kim, Y Han, H Kim, W Kwon, A Lee, YA Suh, J Park, Y Choi, J Namkung, SG Yi, H Kim, J Yu, Y Kim, MS Kwon, DY Oh, SW Kim, SY Jeong, W Han, KE Lee, JS Heo, JO Park, JK Park, SC Kim, CM Kang, WJ Lee, S Lee, S Han, JY Jang,
Presenter: Yoo Jin Choi | Seoul National University Hospital

3:55pm EDT – 4:00pm EDT
54. TRANSATLANTIC COMPARISON OF NATIONWIDE AUDITS ON PANCREATIC SURGERY IN THE USA, GERMANY, THE NETHERLANDS, AND SWEDEN
TM Mackay, EM Gleeson, UF Wellner, OR Busch,  BG Koerkam EDTp, T Keck, HC van Santvoort, B Tingstedt, HA Pitt, MG Besselink, for the Global Audits on Pancreatic Surgery Group (GAPASURG)
Presenter: Tara Mackay | Academic Medical Center

4:15pm EDT – 4:30pm EDT
57. THE SEQUENCE MATTERS: A PROPENSITY MATCHED ANALYSIS OF THE NATIONAL CANCER DATABASE FOR PATIENTS WITH EARLY STAGE PANCREATIC CANCER UNDERGOING PANCREATICODUODENECTOMY IN THE ERA OF MODERN CHEMOTHERAPY
M Watson, K Thompson, L Musselwhite, J Hwang, E Baker, J Martinie, D Vrochides, D Iannitti, L Ocuin
Presenter: Michael Watson MD | Atrium Health/Carolinas HealthCare System

4:30pm EDT – 4:55pm EDT
58. RESPONSE TO AND SURVIVAL AFTER FIRST-LINE FOLFIRINOX OR GEMCITABINE/NAB-PACLITAXEL FOR LOCALIZED PANCREATIC DUCTAL ADENOCARCINOMA
G Perri, L Prakash, GR Varadhachary, R Wolff, D Fogelman, M Overman, S Pant, M Javle, EJ Koay, J Herman, M Kim, N Ikoma, C Tzeng, JE Lee, MHG Katz
Presenter: Giampaolo Perri MD | University of Texas MD Anderson Cancer Center

4:55pm EDT – 5:00pm EDT
59. REAPPRAISAL OF NODAL STAGING AND STUDY OF LYMPH NODE STATION INVOLVEMENT IN PATIENTS RECEIVING PANCREATICODUODENECTOMY AFTER NEOADJUVANT TREATMENT FOR PANCREATIC DUCTAL ADENOCARCINOMA
L Maggino, A Bottardi, S Nobile, F Casciani, G Lionetto, S Paiella, G Marchegiani, C Bassi, R Salvia, G Malleo
Presenter: Laura Maggino MD, PhD Candidate | University of Verona

5:00pm EDT – 5:05pm EDT
60. THE NOVEL STRATEGY FOR THE PATIENTS WITH POSITIVE PERITONEAL CYTOLOGY AFTER NEOADJUVANT THERAPY IN RESECTABLE/BODERLINE RESECTABLE PANCREAS CANCER
S Aoki, T Takadate, T Hata, T Miura, S Maeda, K Ariake, K Kawaguchi, K Masuda, M Ishida, M Mizuma, H Ohtsuka, H Hayashi, K Nakagawa, T Morikawa, F Motoi, T Naitoh, M Unno
Presenter: Shuichi Aoki | Tohoku University Graduate School of Medicine

5:05pm EDT – 5:20pm EDT
61. SIGNIFICANCE OF “DOMINANT” UNCINATE DUCT DILATATION IN IPM EDTNS: A NEW HIGH-RISK CRITERION
S AlMasri, M Zenati, A Dasyam, A Singhi, K Lee, A Slivka, K Mcgrath, J Chennat, K Fasanella, A Khalid, R Brand, S Sarkaria, R Das, D Bartlett, H Zeh, A Zureikat
Presenter: Samer S Al Masri MD | University of Pittsburgh Medical Center

5:25pm EDT – 5:30pm EDT
63. NERVE GROWTH FACTOR EXPRESSION AND NERVE HYPERTROPHY IN INTRADUCTAL PAPILLARY MUCINOUS NEOPLASMS
VQ Trinh, F Revetta, JTE Roland, K Idrees, C Shi, MCB Tan
Presenter: Vincent Q Trinh MD | Vanderbilt University Medical Center


5:45pm – 6:30pm EDT

 

Virtual Happy Hour

Contact Information

The Pancreas Club Headquarters

t: 913.402.7102
pancreas@lp-etc.com


Information provided on this site is for member benefit use only. Copying or reproducing any of the content and use of our member email list is prohibited. We are happy to review any requests for promotions to our members. Thank you!